胸廓内动脉栓塞在胸部肿瘤术前的应用价值  

Application value of internal thoracic artery embolization before thoracic tumor surgery

作　　者：冯为[1] FENG Wei(Department of Thoracic Surgery,Jiamusi Central Hospital in Heilongjiang Province,Jiamusi154002,China)

机构地区：[1]黑龙江省佳木斯市中心医院胸外科

出　　处：《中国现代医生》2020年第1期101-103,共3页China Modern Doctor

摘　　要：目的 分析胸廓内动脉栓塞在胸部肿瘤术前的应用价值。方法 选取2017年11月~2018年11月期间在我院收治的50例胸部肿瘤患者,随机分成两组,每组25例;实验组术前给予胸廓内动脉栓塞,对照组未行胸廓内动脉栓塞,两组均行胸部肿瘤术。观察两组患者的术中输血量、治疗效果及术后不良反应。结果 实验组术中出血量明显少于对照组,且不良反应发生率为8.00%,明显低于对照组的32.00%,差异有统计学意义(P<0.05)。结论 术前胸廓内动脉栓塞在胸部肿瘤手术中的应用能够提高手术疗效,降低出血量,无明显并发症,值得临床大量推广。Objective To analyze the value of internal thoracic artery embolization before thoracic tumor surgery.Methods Fifty patients with chest tumors admitted to our hospital from November 2017 to November 2018 were randomly divided into two groups,with 25 patients in each group.The experimental group was given internal thoracic artery embolization before operation and the control group was not given internal thoracic artery embolization.Then thoracic tumor surgery was performed in both groups.The intraoperative blood transfusion volume,treatment effects and postoperative adverse reactions in the two groups were observed.Results The amount of bleeding in the experimental group was significantly lower than that in the control group,and the incidence of adverse reactions in the experimental group was 8.00%,which was significantly lower than that in the control group(32.00%),with significant differences(P<0.05).Conclusion Preoperative internal thoracic artery embolization can improve the curative effects of surgery and reduce the amount of bleeding without obvious complications,which is worthy of clinical promotion.

关 键 词：胸部肿瘤 胸廓内动脉栓塞 术前 不良反应 

分 类 号：R730.56[医药卫生—肿瘤]